MapLight Therapeutics, Inc.
MPLT
$13.71
-$0.24-1.72%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -148.65% | -146.32% | -107.72% | -- | -- |
| Total Depreciation and Amortization | -14.35% | -20.28% | -17.55% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6,293.62% | 12,304.78% | 3,024.27% | -- | -- |
| Change in Net Operating Assets | 135.20% | -99.78% | -318.79% | -- | -- |
| Cash from Operations | -73.18% | -93.98% | -75.27% | -- | -- |
| Capital Expenditure | 17.03% | 35.29% | 38.57% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -359.01% | -589.60% | -303.33% | -- | -- |
| Cash from Investing | -360.95% | -578.51% | -300.07% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 747,835.14% | 93,678.64% | 93,777.89% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 65.79% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -988.24% | -121.63% | -129.27% | -- | -- |
| Cash from Financing | 114,486.17% | 23,881.00% | 297.95% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 820.66% | 104.28% | 120.40% | -- | -- |